ITRM20050389A1 - Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. - Google Patents
Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.Info
- Publication number
- ITRM20050389A1 ITRM20050389A1 IT000389A ITRM20050389A ITRM20050389A1 IT RM20050389 A1 ITRM20050389 A1 IT RM20050389A1 IT 000389 A IT000389 A IT 000389A IT RM20050389 A ITRM20050389 A IT RM20050389A IT RM20050389 A1 ITRM20050389 A1 IT RM20050389A1
- Authority
- IT
- Italy
- Prior art keywords
- receptors
- egf
- compounds
- medical fields
- specific salts
- Prior art date
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 102000005962 receptors Human genes 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Priority Applications (34)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000389A ITRM20050389A1 (it) | 2005-07-22 | 2005-07-22 | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| US11/989,090 US8153841B2 (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| PT67660852T PT1910270E (pt) | 2005-07-22 | 2006-07-24 | Compostos e seus sais específicos para os receptores ppar e os receptores de egf e sua utilização no campo médico |
| EP06766085.2A EP1910270B3 (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| NZ566045A NZ566045A (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| JP2008522170A JP5312026B2 (ja) | 2005-07-22 | 2006-07-24 | Ｐｐａｒ受容体及びｅｇｆ受容体に特異的な化合物及びそれらの塩並びに医療分野におけるそれらの使用 |
| DK06766085.2T DK1910270T6 (en) | 2005-07-22 | 2006-07-24 | For PPAR receptors and EGF receptors specific compounds and their salts as well as their application in the medical field |
| ES06766085.2T ES2421260T7 (es) | 2005-07-22 | 2006-07-24 | Compuestos y sus sales específicos de los receptores PPAR y los receptores del EGF, y su uso en el campo de la medicina |
| BRPI0613396-7A BRPI0613396B1 (pt) | 2005-07-22 | 2006-07-24 | Composto, uso do mesmo, e, composição farmacêutica |
| EA201000708A EA017566B1 (ru) | 2005-07-22 | 2006-07-24 | Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины |
| CN2006800300777A CN101243039B (zh) | 2005-07-22 | 2006-07-24 | Ppar受体和egf受体特异性化合物及其盐以及它们在医药领域中的用途 |
| PCT/IE2006/000078 WO2007010516A2 (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| PL06766085T PL1910270T6 (pl) | 2005-07-22 | 2006-07-24 | Związki i ich sole swoiste dla receptorów PPAR i receptorów EGF oraz ich zastosowanie w medycynie |
| HRP20130549TT HRP20130549T4 (hr) | 2005-07-22 | 2006-07-24 | Spojevi i njihove soli specifični za ppar receptore i egf receptore te njihova primjena u području medicine |
| NZ592228A NZ592228A (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| EA200800372A EA014665B3 (ru) | 2005-07-22 | 2006-07-24 | Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины |
| SI200631598T SI1910270T1 (sl) | 2005-07-22 | 2006-07-24 | Spojine in njihove soli specifične za PPar receptorje in EGF receptorje in njihova uporaba na medicinskem področju |
| CA2616146A CA2616146C (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| CN2010105208008A CN102020577B (zh) | 2005-07-22 | 2006-07-24 | Ppar受体和egf受体特异性化合物及其盐以及它们在医药领域中的用途 |
| UAA200802141A UA100359C2 (uk) | 2005-07-22 | 2006-07-24 | Сполуки та їхні солі, які є специфічними для ппар-рецепторів та фре-рецепторів, а також їх використання у медичній галузі |
| KR1020087003953A KR101317519B1 (ko) | 2005-07-22 | 2006-07-24 | Ｐｐａｒ 수용체 및 ｅｇｆ 수용체에 특이적인 화합물 및이들의 염, 및 의학 분야에서의 이들의 용도 |
| AU2006271165A AU2006271165C1 (en) | 2005-07-22 | 2006-07-24 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| MX2013012753A MX366596B (es) | 2005-07-22 | 2006-07-24 | Compuestos y sus sales especificas de receptores de ppar y egf y su uso en el campo medico. |
| IL188878A IL188878A (en) | 2005-07-22 | 2008-01-17 | Compounds and their special salts for ppar and egf receptors and their use in the medical field |
| NO20080325A NO340680B1 (no) | 2005-07-22 | 2008-01-18 | Forbindelser og deres salter som er spesifikke overfor PPAR-reseptorer og EGF-reseptorer samt deres anvendelse innen medisin |
| ZA2008/01671A ZA200801671B (en) | 2005-07-22 | 2008-02-20 | Compounds and their salts specific to the ppar receptors and the egf recepters and their use in the medical fields |
| IL205992A IL205992A (en) | 2005-07-22 | 2010-05-26 | Compounds and their special salts for ppar and egf receptors and their use in drug preparation |
| ZA2010/08268A ZA201008268B (en) | 2005-07-22 | 2010-11-18 | Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field |
| US13/408,439 US8710100B2 (en) | 2005-07-22 | 2012-02-29 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| CY20131100562T CY1114294T1 (el) | 2005-07-22 | 2013-07-05 | Ενωσεις και τα αλατα τους που αφορουν τους υποδοχεις ppar και τους υποδοχεις egf kai h χρηση τους στον τομεα της ιατρικης |
| US14/202,386 US9133099B2 (en) | 2005-07-22 | 2014-03-10 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| US14/671,579 US9561202B2 (en) | 2005-07-22 | 2015-03-27 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| US14/671,585 US9345680B2 (en) | 2005-07-22 | 2015-03-27 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
| US15/377,013 US10016381B2 (en) | 2005-07-22 | 2016-12-13 | Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000389A ITRM20050389A1 (it) | 2005-07-22 | 2005-07-22 | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITRM20050389A1 true ITRM20050389A1 (it) | 2007-01-23 |
Family
ID=37579831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000389A ITRM20050389A1 (it) | 2005-07-22 | 2005-07-22 | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
Country Status (23)
| Country | Link |
|---|---|
| US (6) | US8153841B2 (https=) |
| EP (1) | EP1910270B3 (https=) |
| JP (1) | JP5312026B2 (https=) |
| KR (1) | KR101317519B1 (https=) |
| CN (2) | CN101243039B (https=) |
| AU (1) | AU2006271165C1 (https=) |
| CA (1) | CA2616146C (https=) |
| CY (1) | CY1114294T1 (https=) |
| DK (1) | DK1910270T6 (https=) |
| EA (2) | EA014665B3 (https=) |
| ES (1) | ES2421260T7 (https=) |
| HR (1) | HRP20130549T4 (https=) |
| IL (2) | IL188878A (https=) |
| IT (1) | ITRM20050389A1 (https=) |
| MX (1) | MX366596B (https=) |
| NO (1) | NO340680B1 (https=) |
| NZ (2) | NZ566045A (https=) |
| PL (1) | PL1910270T6 (https=) |
| PT (1) | PT1910270E (https=) |
| SI (1) | SI1910270T1 (https=) |
| UA (1) | UA100359C2 (https=) |
| WO (1) | WO2007010516A2 (https=) |
| ZA (2) | ZA200801671B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| IE20070129A1 (en) * | 2007-02-28 | 2008-12-24 | Giuliani Int Ltd | Ppar-gamma agonists stimulate enteric defensin expression |
| ITMI20072429A1 (it) | 2007-12-24 | 2009-06-25 | Giuliani Int Ltd | Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| SI2805746T1 (sl) | 2009-02-16 | 2020-10-30 | Nogra Pharma Limited | Alkilamido spojine in njihova uporaba |
| CN102906074A (zh) | 2010-05-24 | 2013-01-30 | 东亚荣养株式会社 | 稠合咪唑衍生物 |
| CA2864059C (en) * | 2012-02-09 | 2020-04-28 | Nogra Pharma Limited | Methods of treating fibrosis |
| MX2014012652A (es) * | 2012-04-18 | 2014-11-25 | Nogra Pharma Ltd | Metodo de tratamiento de la intolerancia a la lactosa. |
| FR2996545B1 (fr) | 2012-10-08 | 2016-03-25 | Ecole Polytech | Procede microfluidique de traitement et d'analyse d'une solution contenant un materiel biologique, et circuit microfluidique correspondant. |
| US10257875B2 (en) * | 2014-03-20 | 2019-04-09 | Kyocera Corporation | User terminal, communication control method, and base station |
| WO2017093444A1 (en) * | 2015-12-01 | 2017-06-08 | Nogra Pharma Limited | Compositions for oral administration in the treatment of inflammatory bowel disease |
| EP3914227A1 (en) | 2019-01-25 | 2021-12-01 | Nogra Pharma Limited | Compositions for use in preventing acne |
| EP4495101A3 (en) | 2019-02-08 | 2025-04-30 | Nogra Pharma Limited | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof |
| TW202541791A (zh) | 2023-12-20 | 2025-11-01 | 愛爾蘭商諾格拉製藥有限公司 | 痤瘡局部用調配物 |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB767788A (en) | 1953-12-28 | 1957-02-06 | Schering Corp | Polyiodinated phenyl fatty acid compounds and process for their manufacture |
| US3211610A (en) * | 1961-09-29 | 1965-10-12 | Merck & Co Inc | Benzoic acid ester derivatives for treating coccidiosis and method of using same |
| US3444232A (en) * | 1966-05-18 | 1969-05-13 | Squibb & Sons Inc | O-alkyl or phenylalkyl benzohydroxamic acids |
| GB1359560A (en) | 1972-02-25 | 1974-07-10 | Merck & Co Inc | Preparation of pyrrylsalicylic acid |
| US4036951A (en) * | 1973-03-12 | 1977-07-19 | Synergistics, Inc. | Ultra-violet filtration with certain aminosalicylic acid esters |
| FR2440353A1 (fr) * | 1978-11-03 | 1980-05-30 | Science Union & Cie | Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament |
| US4348223A (en) * | 1980-12-05 | 1982-09-07 | Ppg Industries, Inc. | N-Alkyl-N-[3-(alkoxyalkyl)phenyl]-2-haloacetamide herbicides |
| DE3164618D1 (en) * | 1980-12-22 | 1984-08-09 | Schering Ag | 3-substituted 2,4,6-trihalogenobenzamides and their salts, their preparation and their use as substitutes for natural sweetening agents, and sweeteners containing them |
| JPS58194814A (ja) | 1982-05-11 | 1983-11-12 | Nippon Shinyaku Co Ltd | 免疫調節作用を有する薬剤 |
| IL69282A (en) | 1982-09-02 | 1988-06-30 | Euro Celtique Sa | Method for the carboxylation of potassium phenoxide with carbon dioxide |
| DE3786452T2 (de) * | 1987-02-05 | 1993-10-21 | Kureha Chemical Ind Co Ltd | Benzylether-Verbindungen und Verfahren zu ihrer Herstellung. |
| AU1388388A (en) | 1987-04-01 | 1988-10-06 | Dak-Laboratoriet A/S | Benzoic acid derivatives and use thereof |
| EP0352826B1 (en) | 1988-05-05 | 1994-10-26 | Tillotts Pharma Ag | Use of 5-aminosalicylic acid in the treatment of dermatological disorders |
| US5519014A (en) * | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
| DE69133348T3 (de) | 1990-10-22 | 2011-05-12 | Centre for Digestive Diseases Pty, Ltd. | Behandlung von nicht-entzündlichen darmerkrankungen |
| US5262549A (en) * | 1991-05-30 | 1993-11-16 | Polaroid Corporation | Benzpyrylium dyes, and processes for their preparation and use |
| US5302751A (en) | 1992-01-21 | 1994-04-12 | Ethyl Corporation | Profen resolution |
| DE69331727D1 (de) | 1992-06-30 | 2002-04-25 | Howard K Shapiro | Verwendung einer kombination bestehend aus einem aminderivat oder aminverwandten derivat der benzoesäure und einem amino-polysaccharide zur herstellung eines medikaments fuer die behandlung von entzündlichen erkrankungen |
| US5594151A (en) * | 1994-01-28 | 1997-01-14 | Prolinx, Inc. | Phenylboronic acid complexing reagents derived from aminosalicylic acid |
| CA2190107A1 (en) | 1994-05-11 | 1995-11-23 | Secant Pharma, Llc | Compositions for treatment of chronic inflammatory diseases |
| US5594015A (en) | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
| WO1996030016A2 (en) | 1995-03-28 | 1996-10-03 | Janssen Pharmaceutica N.V. | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases |
| US5939442A (en) * | 1995-06-07 | 1999-08-17 | The Salk Institute For Biological Studies | Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof |
| GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9617001D0 (en) | 1996-08-13 | 1996-09-25 | Tillotts Pharma Ag | Oral composition |
| DE19647582A1 (de) * | 1996-11-18 | 1998-05-20 | Hoechst Ag | Verfahren zur Herstellung von aromatischen Olefinen mittels Katalyse durch Palladaphosphacyclobutane |
| WO1998043081A1 (en) | 1997-03-26 | 1998-10-01 | Ligand Pharmaceuticals Incorporated | Treatment of gastrointestinal disease with ppar modulators |
| US7098025B1 (en) * | 1997-07-25 | 2006-08-29 | Ligand Pharmaceuticals Incorporated | Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor |
| AU9002798A (en) * | 1997-09-19 | 1999-04-12 | Ono Pharmaceutical Co. Ltd. | Fused or nonfused benzene compounds |
| FR2773075B1 (fr) | 1997-12-31 | 2000-05-05 | Cird Galderma | Utilisation d'activateurs de ppar-gamma en dermatologie |
| US6114382A (en) | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
| US6326364B1 (en) * | 1999-02-08 | 2001-12-04 | Cedars-Sinai Medical Center | Use of 5-aminosalicylates as antimicrobial agents |
| FR2791671B1 (fr) | 1999-04-01 | 2001-05-11 | Oreal | Nouveaux composes derives d'esters d'acide benzoique, composition les comprenant et utilisation |
| GB9908647D0 (en) | 1999-04-15 | 1999-06-09 | Smithkline Beecham Plc | Novel compounds |
| US20040034067A1 (en) * | 1999-04-15 | 2004-02-19 | Macphee Colin Houston | Novel method of treatment |
| GB9914371D0 (en) | 1999-06-18 | 1999-08-18 | Smithkline Beecham Plc | Novel compounds |
| TWI262185B (en) | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
| ATE275127T1 (de) | 2000-04-19 | 2004-09-15 | Neurotech Co Ltd | Verbindungen, zusammensetzungen und verfahren zur vorbeugung der neurodegeneration bei akuten oder chronischen verletzungen des zentralen nervensystems |
| DE60135742D1 (de) * | 2000-05-29 | 2008-10-23 | Kyorin Seiyaku Kk | Substituierte phenylpropionsäure-derivate |
| US7049342B2 (en) | 2000-05-29 | 2006-05-23 | Kyorin Pharmaceutical Co., Ltd. | Substituted phenylpropionic acid derivatives |
| WO2002018324A2 (en) | 2000-08-29 | 2002-03-07 | Nobex Corporation | Immunoregulatory compounds, derivatives thereof and their use |
| AU2002222574A1 (en) | 2000-12-05 | 2002-06-18 | Kyorin Pharmaceutical Co. Ltd. | Substituted carboxylic acid derivatives |
| FR2822955B1 (fr) | 2001-03-27 | 2003-10-03 | Chru Lille | Methode de diagnostic de maladies inflammatoires chroniques de l'intestin |
| WO2002085123A1 (en) | 2001-04-18 | 2002-10-31 | Merck & Co., Inc. | Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| CA2354921A1 (en) | 2001-05-24 | 2002-11-24 | Yasuo Konishi | Drug evolution: drug design at hot spots |
| US20110105748A1 (en) * | 2001-10-16 | 2011-05-05 | Debnath Bhuniya | Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| UA82835C2 (en) * | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
| US20030113815A1 (en) * | 2001-12-19 | 2003-06-19 | Pfizer Inc. | Canine peroxisome proliferator activated receptor gamma |
| US20030220374A1 (en) * | 2002-01-14 | 2003-11-27 | Pharmacia Corporation | Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors |
| US20040115127A1 (en) * | 2002-04-12 | 2004-06-17 | Wright Samuel D. | Ppar-alpha-gamma ligands or agonists for the treatment of inflammation |
| GB0303609D0 (en) | 2003-02-17 | 2003-03-19 | Glaxo Group Ltd | Novel therapeutic method and compositions |
| US20060159648A1 (en) | 2003-02-17 | 2006-07-20 | Davis Adrian F | Novel therapeutic method and compositions for topical administration |
| US20060177444A1 (en) * | 2003-03-20 | 2006-08-10 | Tatsuo Horizoe | Concomitant drug as therapeutic agent for inflammatory bowel disease |
| EP1654247B1 (en) | 2003-07-21 | 2010-01-20 | Merck Serono SA | Alkynyl aryl carboxamides |
| GB2422782A (en) | 2003-10-21 | 2006-08-09 | Inspire Pharmaceuticals Inc | Non-nucleotide compositions and method for treating pain |
| US20070093476A1 (en) * | 2003-10-28 | 2007-04-26 | Bhunia Debnath | Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them |
| JP2007513173A (ja) | 2003-12-03 | 2007-05-24 | スミスクライン・ビーチャム・コーポレイション | ロシグリタゾンを用いる乾癬の治療 |
| WO2005072113A2 (en) | 2004-01-20 | 2005-08-11 | Harty Richard F | Compositions and methods of treatment for inflammatory diseases |
| WO2005084658A1 (en) | 2004-03-04 | 2005-09-15 | Arakis Ltd. | Derivatives of actarit and their therapeutic use |
| US20060286046A1 (en) | 2005-01-05 | 2006-12-21 | Haber C Andrew | Skin care compositions |
| US20060270635A1 (en) * | 2005-05-27 | 2006-11-30 | Wallace John L | Derivatives of 4- or 5-aminosalicylic acid |
| ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| ITRM20050390A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
| DE102005061472A1 (de) | 2005-12-22 | 2007-07-05 | Saltigo Gmbh | Verfahren zur Herstellung von enantiomerenangereicherten 2-Alkoxy-3-phenylpropionsäuren |
| WO2007096148A1 (en) | 2006-02-23 | 2007-08-30 | Lipid Nutrition B.V. | Immunoregulation |
| US7645801B2 (en) | 2007-01-29 | 2010-01-12 | Alaven Pharmaceutical Llc | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
| IE20070129A1 (en) | 2007-02-28 | 2008-12-24 | Giuliani Int Ltd | Ppar-gamma agonists stimulate enteric defensin expression |
| WO2009025854A1 (en) | 2007-08-22 | 2009-02-26 | Burnham Institute For Medical Research | Smips: small molecule inhibitors of p27 depletion in cancers and other proliferative diseases |
| ITMI20072429A1 (it) | 2007-12-24 | 2009-06-25 | Giuliani Int Ltd | Composti per il trattamento selettivo della componente immuno-infiammatoria intestinale della malattia celiaca |
| US8030520B2 (en) | 2008-03-31 | 2011-10-04 | Saltigo Gmbh | Process for preparing organic compounds by a transition metal-catalysed cross-coupling reaction of an aryl-X, heteroaryl-X, cycloalkenyl-X or alkenyl-X compound with an alkyl, alkenyl, cycloalkyl or cycloalkenyl halide |
| UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
| SI2805746T1 (sl) | 2009-02-16 | 2020-10-30 | Nogra Pharma Limited | Alkilamido spojine in njihova uporaba |
| EP2298321A1 (en) | 2009-08-26 | 2011-03-23 | Nordic Pharma | Novel pharmaceutical compositions for treating IBD |
| EP2731605A4 (en) | 2011-07-15 | 2015-02-25 | Sla Pharma Ag | Pharmaceutical compositions for rectal administration |
| WO2013064153A1 (en) | 2011-10-31 | 2013-05-10 | Claus Selch Larsen | Prodrugs of non- steroid anti - inflammatory agents (nsaids) |
| CA2864059C (en) | 2012-02-09 | 2020-04-28 | Nogra Pharma Limited | Methods of treating fibrosis |
| MX2014012652A (es) | 2012-04-18 | 2014-11-25 | Nogra Pharma Ltd | Metodo de tratamiento de la intolerancia a la lactosa. |
| US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
| MX2014014657A (es) | 2012-06-01 | 2015-08-10 | Nogra Pharma Ltd | Heterociclos bicíclicos capaces de modular las respuestas de los linfocitos t, y métodos de uso de los mismos. |
| KR20150053974A (ko) | 2012-09-13 | 2015-05-19 | 노그라 파마 리미티드 | 모발 성장 억제 방법 |
| EP2895160B1 (en) | 2012-09-13 | 2018-05-30 | Nogra Pharma Limited | Methods of treating hair related conditions |
| WO2016154730A1 (en) | 2015-04-02 | 2016-10-06 | University Health Network | Gut anti-inflammatory agents for regulation of high blood glucose levels |
| DK3307262T3 (da) | 2015-06-15 | 2021-08-09 | Nmd Pharma As | Forbindelser til anvendelse ved behandling af neuromuskulære lidelser |
-
2005
- 2005-07-22 IT IT000389A patent/ITRM20050389A1/it unknown
-
2006
- 2006-07-24 CN CN2006800300777A patent/CN101243039B/zh active Active
- 2006-07-24 DK DK06766085.2T patent/DK1910270T6/en active
- 2006-07-24 WO PCT/IE2006/000078 patent/WO2007010516A2/en not_active Ceased
- 2006-07-24 MX MX2013012753A patent/MX366596B/es unknown
- 2006-07-24 ES ES06766085.2T patent/ES2421260T7/es active Active
- 2006-07-24 UA UAA200802141A patent/UA100359C2/uk unknown
- 2006-07-24 EP EP06766085.2A patent/EP1910270B3/en active Active
- 2006-07-24 SI SI200631598T patent/SI1910270T1/sl unknown
- 2006-07-24 AU AU2006271165A patent/AU2006271165C1/en not_active Ceased
- 2006-07-24 PL PL06766085T patent/PL1910270T6/pl unknown
- 2006-07-24 KR KR1020087003953A patent/KR101317519B1/ko active Active
- 2006-07-24 EA EA200800372A patent/EA014665B3/ru active IP Right Maintenance
- 2006-07-24 CN CN2010105208008A patent/CN102020577B/zh active Active
- 2006-07-24 NZ NZ566045A patent/NZ566045A/en unknown
- 2006-07-24 PT PT67660852T patent/PT1910270E/pt unknown
- 2006-07-24 US US11/989,090 patent/US8153841B2/en active Active
- 2006-07-24 HR HRP20130549TT patent/HRP20130549T4/hr unknown
- 2006-07-24 EA EA201000708A patent/EA017566B1/ru not_active IP Right Cessation
- 2006-07-24 CA CA2616146A patent/CA2616146C/en active Active
- 2006-07-24 NZ NZ592228A patent/NZ592228A/xx unknown
- 2006-07-24 JP JP2008522170A patent/JP5312026B2/ja not_active Expired - Fee Related
-
2008
- 2008-01-17 IL IL188878A patent/IL188878A/en active IP Right Review Request
- 2008-01-18 NO NO20080325A patent/NO340680B1/no unknown
- 2008-02-20 ZA ZA2008/01671A patent/ZA200801671B/en unknown
-
2010
- 2010-05-26 IL IL205992A patent/IL205992A/en active IP Right Grant
- 2010-11-18 ZA ZA2010/08268A patent/ZA201008268B/en unknown
-
2012
- 2012-02-29 US US13/408,439 patent/US8710100B2/en active Active
-
2013
- 2013-07-05 CY CY20131100562T patent/CY1114294T1/el unknown
-
2014
- 2014-03-10 US US14/202,386 patent/US9133099B2/en active Active
-
2015
- 2015-03-27 US US14/671,579 patent/US9561202B2/en active Active
- 2015-03-27 US US14/671,585 patent/US9345680B2/en active Active
-
2016
- 2016-12-13 US US15/377,013 patent/US10016381B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL188878A0 (en) | Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field | |
| SMT201500206B (it) | Composti spiro-ossindolici e loro uso come agenti terapeutici | |
| EP2130875A4 (en) | CYANINE CONNECTION, OPTICAL FILTER WITH CONNECTION AND OPTICAL RECORDING MATERIAL | |
| BRPI0618904A2 (pt) | composto, composição farmacêutica, e, uso do composto | |
| EP2209420A4 (en) | PARTICULARS FOR IMAGING | |
| EP2123158A4 (en) | HERBICIDE COMPOSITION | |
| BRPI0817542A2 (pt) | NOVOS INIBIDORES DE sEH E SEU USO | |
| IL235943A0 (en) | Genistein salts, crystalline forms of same, compositions comprising same and uses thereof | |
| ITRM20050390A1 (it) | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. | |
| BRPI0813587A2 (pt) | Composto, uso do mesmo, e, composição farmacêutica | |
| EP2188781A4 (en) | IMAGE RECONSTRUCTION | |
| BRPI0806529A2 (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta | |
| ITPN20050014A1 (it) | "piedino livellatore perfezionato" | |
| BRPI0924525A2 (pt) | "derivativos de colestanol para uso combinado" | |
| FR2902340B1 (fr) | Composition cosmetique a usage topique comprenant du wasabi | |
| BRPI0612406A2 (pt) | sal de estrôncio, e, uso do mesmo | |
| EP2305304A4 (en) | IMMUNOSTIMULATOR WITH EP1 AGONIST | |
| ITMI20051155A1 (it) | Nuovi composti fluorurati, loro sintesi e uso. | |
| EP1990733A4 (en) | ERROR DETECTOR | |
| BRPI0819055A2 (pt) | "uso de 3-(2,2,2-trimetilhidrazina) propionato e seus sais" | |
| ITMI20051695A1 (it) | Uso di 17a-esteri c3-c10 del 9,11-deidrocortexolone cme agenti anti-gonadotropinici | |
| BRPI0822068A2 (pt) | Derivado de 17-(-1'-propenil)-17-3'-oxidoestra-4-en-3-ona, seu uso e o medicamento contendo o derivado | |
| ES1064362Y (es) | "ventana perfeccionada" | |
| ITSA20050013A1 (it) | Spazzolino srotolabile pronto uso per l'igiene orale | |
| ITTO20050042U1 (it) | Maschere per attivita' acquatiche |